Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

James Marcouillier

Physician Assistant Forest, VA Physician Assistant

NPI 1508411323 CMS profile 10511684

853 Leander Drive, Forest, VA 24551

Open in the dashboard

General payments

$16,822

76 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Marcouillier of Forest, VA is reported in the CMS Open Payments database as having received $16,822 across 76 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,118 22
2024 General $5,113 19
2023 General $403 9
2022 General $1,306 10
2021 General $883 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Marcouillier
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to James Marcouillier were reported at $9,118. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year James Marcouillier Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $883 $132 $37–$438 $132
2022 $1,306 $155 $48–$522 $149
2023 $403 $167 $52–$557 $160
2024 $5,113 $178 $55–$600 $164
2025 $9,118 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $8,953 19 payments
  2. Silk Road Medical, Inc. $5,870 23 payments
  3. Medtronic, Inc. $1,299 23 payments
  4. Medical Device Business Services, Inc. $509 6 payments
  5. Maquet Cardiovascular U.S. Sales, L.L.C. $78 1 payment
  6. Pacira Pharmaceuticals Incorporated $51 1 payment
  7. Bioprotect Medical, Inc. $42 2 payments
  8. Smith+Nephew, Inc. $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,880 5 payments
  2. Travel and Lodging $3,765 12 payments
  3. Food and Beverage $3,518 52 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $2,400 1 payment
  5. Consulting Fee $1,000 2 payments
  6. Education $260 4 payments
Products named General payments · program years 2021–2025
  1. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $5,870 23 payments
  2. ENROUTE Transcarotid Stent $5,870 23 payments
  3. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $4,793 13 payments
  4. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $4,793 13 payments
  5. ENROUTE Transcarotid Neuroprotection System Cardiology Vascular Diseases $3,917 5 payments
  6. ENROUTE Transcarotid Neuroprotection System Enroute Nps Angle US - Pi $3,613 7 payments
  7. General - Vascular Intervention $1,338 4 payments
  8. Valiant Captivia $491 7 payments
  9. ENDURANT IIS $359 6 payments
  10. Heli-FX EndoAnchor System $281 6 payments
  11. Other $766 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

306

Median for Physician Assistant: 241

Drug cost

$18,586

Median for Physician Assistant: $4,110

Branded share of claims

51.6%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 25 $16,547
Clopidogrel Clopidogrel Bisulfate Brand 91 $737
Atorvastatin Calcium Generic 45 $618
Doxycycline Hyclate Generic 11 $192
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 15 $150
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 27 $114
Tramadol Hcl Generic 61 $107
Gabapentin Generic 19 $89
Oxycodone Hcl Generic 12 $31

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$12,200

Medicare's payments for the services billed

Medicare patients

174

Average age 75

Services billed

238

66 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 57%
Diabetes 53%
Ischemic heart disease 53%
Arthritis 46%
Heart failure 43%
Atrial fibrillation 34%
Depression 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

76 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record